StockData
Ceribell, Inc. logo

Ceribell, Inc. (CBLL) stock

CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value
$25.63−0.34 (-1.31%)

Close on Nov 18, 2026Market cap $983.63MP/E –Yield –

Ceribell net income

Net income is the profit left for shareholders after every expense, interest and tax.

Ceribell's net income for the twelve months ending Jun 30, 2026 was -$66.00M. For fiscal 2025 it was -$53.41M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$53.41M–
FY2024Dec 31, 2024-$40.46M–
FY2023Dec 31, 2023-$29.46M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$19.27M–
Q1 FY2026Mar 31, 2026-$19.74M–
Q4 FY2025Dec 31, 2025-$13.53M–
Q3 FY2025Sep 30, 2025-$13.47M–
Q2 FY2025Jun 30, 2025-$13.64M–
Q1 FY2025Mar 31, 2025-$12.78M–
Q4 FY2024Dec 31, 2024-$12.58M–
Q3 FY2024Sep 30, 2024-$10.42M–
Q2 FY2024Jun 30, 2024-$8.94M–
Q1 FY2024Mar 31, 2024-$8.52M–
Q4 FY2023Dec 31, 2023-$8.27M–
Q3 FY2023Sep 30, 2023-$7.05M–
Q2 FY2023Jun 30, 2023-$6.22M–
Q1 FY2023Mar 31, 2023-$7.92M–

More Ceribell figures

See a number that looks wrong?